Predictors of biochemical aspirin and clopidogrel resistance in patients with ischemic stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 20, Issue 3, 2011, Pages 227-230

  Fong, Joanna ^a,b   Cheng Ching, Esteban ^a   Hussain, Muhammad Shazam ^a   Katzan, Irene ^b   Gupta, Rishi ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Antiplatelets aspirin; clopidogrel; ischemic stroke; platelet resistance

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEMOGLOBIN A1C;

ADULT; AFRICAN AMERICAN; ARTICLE; BRAIN ISCHEMIA; COMBINATION CHEMOTHERAPY; CONGESTIVE HEART FAILURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TREATMENT RESPONSE;

AFRICAN AMERICANS; AGED; ASPIRIN; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; OHIO; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TICLOPIDINE; TREATMENT OUTCOME;

EID: 79955515500     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2009.12.004     Document Type: Article

References (20)

1. C.B. Wang, D.Y. Hu, and X.B. Shi Aspirin resistance in patients taking small dose of aspirin Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 18 2006 219 223
2. E. Shantsila, T. Watson, and G.Y. Lip Aspirin resistance: What, why and when? Thromb Res 119 2007 551 554
3. S. Sanderson, J. Emery, and T. Baglin Narrative review: Aspirin resistance and its clinical implications Ann Intern Med 142 2005 370 380 (Pubitemid 40293410)
4. T.S. Poulsen, B. Jorgensen, and L. Korsholm Prevalence of aspirin resistance in patients with an evolving acute myocardial infarction Thromb Res 119 2007 555 562 (Pubitemid 46321503)
5. L. Macchi, N. Sorel, and L. Christiaens Aspirin resistance: Definitions, mechanisms, prevalence, and clinical significance Curr Pharm Des 12 2006 251 258
6. G.J. Hankey, and J.W. Eikelboom Aspirin resistance Lancet 367 2006 606 617 (Pubitemid 43250663)
7. J.W. Eikelboom, J. Hirsh, and J.I. Weitz Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events Circulation 105 2002 1650 1655 (Pubitemid 34298607)
8. P.A. Gum, K. Kottke-Marchant, and P.A. Welsh A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease J Am Coll Cardiol 41 2003 961 965 (Pubitemid 36315537)
9. P. Harrison, H. Segal, and K. Blasbery Screening for aspirin responsiveness after transient ischemic attack and stroke: Comparison of 2 point-of-care platelet function tests with optical aggregometry Stroke 36 2005 1001 1005 (Pubitemid 40629292)
10. P. Harrison, H. Segal, and L. Silver Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests Platelets 19 2008 119 124 (Pubitemid 351302375)
11. M.R. Mueller, A. Salat, and P. Stangl Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty Thromb Haemost 78 1997 1003 1007 (Pubitemid 27417291)
12. B. Pamukcu, H. Oflaz, and I. Onur Clinical relevance of aspirin resistance in patients with stable coronary artery disease: A prospective follow-up study (PROSPECTAR) Blood Coagul Fibrinolysis 18 2007 187 192 (Pubitemid 46232841)
13. T.H. Wang, D.L. Bhatt, and E.J. Topol Aspirin and clopidogrel resistance: An emerging clinical entity Eur Heart J 27 2006 647 654
14. P.A. Gum, K. Kottke-Marchant, and E.D. Poggio Profile and prevalence of aspirin resistance in patients with cardiovascular disease Am J Cardiol 88 2001 230 235 (Pubitemid 32721947)
15. D.C. Sane, S.A. McKee, and A.I. Malinin Frequency of aspirin resistance in patients with congestive heart failure treated with antecedent aspirin Am J Cardiol 90 2002 893 895
16. G. Anfossi, and M. Trovati Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: Implications for anti-aggregating therapy Cardiovasc Hematol Agents Med Chem 4 2006 111 128 (Pubitemid 43805195)
17. P. Ferroni, S. Basili, and A. Falco Platelet activation in type 2 diabetes mellitus J Thromb Haemost 2 2004 1282 1291 (Pubitemid 40186123)
18. C. Watala, M. Boncler, and P. Gresner Blood platelet abnormalities and pharmacological modulation of platelet reactivity in patients with diabetes mellitus Pharmacol Rep 57 Suppl 2005 42 58
19. G. Davi, P. Alessandrini, and A. Mezzetti In vivo formation of 8-epi-prostaglandin F2 alpha is increased in hypercholesterolemia Arterioscler Thromb Vasc Biol 17 1997 3230 3235 (Pubitemid 28016082)
20. A. Csiszar, G. Stef, and P. Pacher Oxidative stress-induced isoprostane formation may contribute to aspirin resistance in platelets Prostagland Leukot Essent Fatty Acids 66 2002 557 558